These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8668331)
21. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043 [TBL] [Abstract][Full Text] [Related]
22. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751 [TBL] [Abstract][Full Text] [Related]
23. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Gottlieb E; Lindner S; Oren M Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860 [TBL] [Abstract][Full Text] [Related]
24. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705 [TBL] [Abstract][Full Text] [Related]
25. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Wang Y; Szekely L; Okan I; Klein G; Wiman KG Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547 [TBL] [Abstract][Full Text] [Related]
26. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Selvakumaran M; Lin HK; Miyashita T; Wang HG; Krajewski S; Reed JC; Hoffman B; Liebermann D Oncogene; 1994 Jun; 9(6):1791-8. PubMed ID: 8183578 [TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis in breast cancer cells by TPA. Li Y; Bhuiyan M; Mohammad RM; Sarkar FH Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997 [TBL] [Abstract][Full Text] [Related]
28. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295 [TBL] [Abstract][Full Text] [Related]
29. An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. Wada M; Hosotani R; Lee JU; Doi R; Koshiba T; Fujimoto K; Miyamoto Y; Tsuji S; Nakajima S; Okuyama A; Imamura M Anticancer Res; 1998; 18(4A):2559-66. PubMed ID: 9703910 [TBL] [Abstract][Full Text] [Related]
30. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1. DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124 [TBL] [Abstract][Full Text] [Related]
31. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Kuo ML; Chou YW; Chau YP; Huang TS Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines. Li JH; Li P; Klamut H; Liu FF Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713 [TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Miyashita T; Krajewski S; Krajewska M; Wang HG; Lin HK; Liebermann DA; Hoffman B; Reed JC Oncogene; 1994 Jun; 9(6):1799-805. PubMed ID: 8183579 [TBL] [Abstract][Full Text] [Related]
34. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J; Le HV; Massagué J Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701 [TBL] [Abstract][Full Text] [Related]
35. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex. Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350 [TBL] [Abstract][Full Text] [Related]
36. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
37. Apoptosis was promoted at a nonpermissive temperature in DNA replication-defective temperature-sensitive mutants of mouse FM3A cells. Yamauchi Y; Tanaka A; Yamaguchi K; Kobayashi M; Shimamura S; Hanaoka F Exp Cell Res; 1998 Feb; 238(2):317-23. PubMed ID: 9473339 [TBL] [Abstract][Full Text] [Related]
38. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Shen XY; Zacal N; Singh G; Rainbow AJ Photochem Photobiol; 2005; 81(2):306-13. PubMed ID: 15560738 [TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Ramondetta L; Mills GB; Burke TW; Wolf JK Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459 [TBL] [Abstract][Full Text] [Related]
40. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Yin Y; Solomon G; Deng C; Barrett JC Mol Carcinog; 1999 Jan; 24(1):15-24. PubMed ID: 10029406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]